Sasaki Takahide, Shibuya Masahiko, Miyazaki Koichi, Nakata Masaya, Kawabe Atsuhiko, Nakasone Takashi, Sakai Nobuaki, Okuno Yuji
Department of Orthopedic Surgery, Wakayama Medical University, 811-1 Kimiidera, Wakayama City, Wakayama 641-8509, Japan; Musculoskeletal Intervention Center, Okuno Clinic Kobe, B1 Fl, 1-2-1, Sannomiyacho, Chuo-ku, Kobe City, Hyogo 650-0021, Japan.
Musculoskeletal Intervention Center, Okuno Clinic Kobe, B1 Fl, 1-2-1, Sannomiyacho, Chuo-ku, Kobe City, Hyogo 650-0021, Japan.
Foot Ankle Surg. 2025 Feb;31(2):105-110. doi: 10.1016/j.fas.2024.07.009. Epub 2024 Jul 27.
Plantar fasciitis (PF) is the most common cause of chronic heel pain, affecting young and older patients.
This retrospective study included patients with PF refractory to conservative treatment who underwent intra-arterial embolization of abnormal neovessels. All patients received temporary embolic material through a needle percutaneously inserted into the posterior tibial artery. The numeric rating scale (NRS) pain score, American Orthopaedic Foot and Ankle Society (AOFAS) score, and procedure-related adverse events were evaluated.
Between January 2020 and February 2022, 66 patients with PF were treated with intra-arterial embolization without major adverse events. The NRS pain score improved significantly, and the AOFAS score increased from 65.8 pre-treatment to 92.8 at 1 year post-treatment. The treatment effect was maintained until the final follow-up (mean duration: 30.9 months).
Ultrasound-guided intraarterial embolization using temporary embolic material may be effective for PF.
IV.
足底筋膜炎(PF)是慢性足跟痛最常见的病因,影响年轻和老年患者。
这项回顾性研究纳入了经保守治疗无效且接受异常新生血管动脉内栓塞治疗的PF患者。所有患者均通过经皮插入胫后动脉的针接受临时栓塞材料。评估数字评定量表(NRS)疼痛评分、美国矫形足踝协会(AOFAS)评分以及与手术相关的不良事件。
在2020年1月至2022年2月期间,66例PF患者接受了动脉内栓塞治疗,未发生重大不良事件。NRS疼痛评分显著改善,AOFAS评分从治疗前的65.8分提高到治疗后1年的92.8分。治疗效果维持至最终随访(平均时长:30.9个月)。
使用临时栓塞材料的超声引导下动脉内栓塞术可能对PF有效。
IV级。